. Author manuscript; available in PMC: 2008 Jul 1.

Published in final edited form as: Am J Obstet Gynecol. 2007 Jul;197(1):3–11. doi: 10.1016/j.ajog.2006.09.025

Table I.

Characteristics of studies included in meta-analysis

Source	Mean follow-up time	Objective Measure	Subjective Measure	No. participants included in analysis	Objective failure	Subjective outcome	Complications	De Novo urgency, frequency
Randomized Trials
Porena,¹³ 2005	13.4 months	Cough stress test	Dry, improved, failed	TO (42)	1	33, 9, 0	2	1
Porena,¹³ 2005	13.4 months	Cough stress test	Dry, improved, failed	RP (47)	3	33, 9, 5	5	5
Mansoor,¹⁴ 2003	6.2 months	Not defined	Questionnaire: cured, failed	TO (48)	--	46, 2	0	1
Mansoor,¹⁴ 2003	6.2 months	Not defined	Questionnaire: cured, failed	RP (54)	--	50, 4	6	10
Kim,¹⁵ 2005	“short term”	Negative cough stress test, pad test	Dry, improved, failed	TO-Monarc (21)	Not reported	17, 4, 0	0	Not reported
Kim,¹⁵ 2005	“short term”	Negative cough stress test, pad test	Dry, improved, failed	RP-SPARC (22)	Not reported	17, 4, 0	1	Not reported
Enzelsberger,¹⁶ 2005	15 months	Not defined	Cured, failed	TO (53)	--	45, 8	0	6
Enzelsberger,¹⁶ 2005	15 months	Not defined	Cured, failed	RP (52)	--	45, 7	7	5
Wang,¹⁷ 2005	6 months (median)	Improved pad weight	Not reported	TO-Monarc (31)	Pre pad weight: 31.8±31.0 Post pad weight: 8.6±21.4	--	0	8
Wang,¹⁷ 2005	6 months (median)	Improved pad weight	Not reported	RP – SPARC (29)	Pre pad weight: 37.2±32.3 Post pad weight: 8.2±21.0	--	2	12
David-Montefiore,¹⁸ 2005	1 month	Not defined	Dry, improved, failed	TO-Istop (46)	--	43, 1, 2	0	9
David-Montefiore,¹⁸ 2005	1 month	Not defined	Dry, improved, failed	RP -Istop (42)	--	39, 2, 1	9	10
Cohort Studies
Kim,¹⁹ 2005	Short term	Not defined	Satisfied, failed	TO (12)	--	12, 0	0	Not reported
Kim,¹⁹ 2005	Short term	Not defined	Satisfied, failed	RP (11)	--	10, 1	0	Not reported
Green,²⁰ 2005	8–10 months	Not defined	Dry, improved, failed	TO (35)	--	28, 3, 4	0	4
Green,²⁰ 2005	8–10 months	Not defined	Dry, improved, failed	RP (40)	--	32, 4, 3	3	5
Miller,²¹ 2006	3.2 months	Urodynamics	Dry, failed	TO-Monarc (85)	8	58, 11	0	(based on Botros²², et al) 0/34
Miller,²¹ 2006	3.2 months	Urodynamics	Dry, failed	RP-Gynecare (60)	2	50, 7	1	10/39
Mellier,²⁴ 2004	TOT – 12.8 months TVT – 29.5 months	Not reported	Dry, improved, failed	TO-Monarc (94)	--	89, 4, 1	2	4
Mellier,²⁴ 2004	TOT – 12.8 months TVT – 29.5 months	Not reported	Dry, improved, failed	RP-Gynecare (99)	--	90, 7, 2	12	3
Fischer,²⁵ 2005	>12 months	Success=pad test <2 grams	Not reported	TO-Monarc, Serasis (220)	42	--	1	TOT – 3
Fischer,²⁵ 2005	>12 months	Success=pad test <2 grams	Not reported	RP-Gynecare (220)	53	--	13	15
Palma,²⁶ 2005	14–18 months	Cough stress test	Dry, improved, failed	TO-SAFYRE (100)	0	94, 2, 4	1	10
Palma,²⁶ 2005	14–18 months	Cough stress test	Dry, improved, failed	RP-SAFYRE (126)	0	116, 3, 7	9	26
Dietz,²⁷ 2005	9 months	Not reported	Dry or improved, or failed	TO-Monarc (58)	--	55, 3	Not reported	Not reported
Dietz,²⁷ 2005	9 months	Not reported	Dry or improved, or failed	RP-Gynecare (56)	--	41,15	Not reported	Not reported
Ansquer,²⁸ 2004	1 month	Not reported	Dry, improved, failed	TO (variety of brands) (24)	--	20, 3, 1	3	1
Ansquer,²⁸ 2004	1 month	Not reported	Dry, improved, failed	RP (25)	--	20, 5, 0	2	1
De Tayrac,²⁹ 2005	21–24 months	Cough stress test	Dry, failed	TO-Mentor Uratape (31)	6	31, 0	0	4
De Tayrac,²⁹ 2005	21–24 months	Cough stress test	Dry, failed	RP-Gynecare (18)	3	18, 0	3	3
Neuman,³⁰ 2006	6 months	--	Subjective outcomes, cough stress test, urodynamics: Cured, failed	TVT-O-Gynecare (75)	--	74, 1	0	Not reported
Neuman,³⁰ 2006	6 months	--		RP-Gynecare (75)	--	73, 2	8	Not reported
Morey,⁵ 2005	9–20 months	Not reported	Pad use=failed	TO – Monarc, ObTape (154)	--	36	0	2
Morey,⁵ 2005	9–20 months	Not reported	Pad use=failed	RP– Gynecare, SPARC (350)	--	70	5	21

TO = Transobturator approach RP = Retropubic approach

Outcomes may not add up to total participants due to loss to follow-up